Skip to content

Sex Differences in E-cig Perception: Study 1

Sex Differences in E-Cigarette Flavor Sensory Perception As It Relates to Appeal and Reinforcing Efficacy Among Adult Smokers: Study 1

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05432830
Enrollment
66
Registered
2022-06-27
Start date
2024-04-30
Completion date
2025-07-18
Last updated
2026-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cigarette Smoking, E-Cig Use, Nicotine Addiction, Sex Differences

Brief summary

The primary objective is to examine the influence of sex on sensory effects, appeal, and reinforcing value of nicotine containing e-cigs in popular flavor components; sweet and cooling.

Detailed description

This study looks at the effect of sex on the sensory effects of flavor components in e-cigarettes. Regular combustible tobacco users will sample 3 different flavored e-cigarettes containing nicotine in a human lab paradigm.

Interventions

OTHERE-liquid Flavor 1

E-liquid containing 36mg/ml pronated nicotine will be administered with sweet e-cigarette flavor.

OTHERE-liquid Flavor 2

E-liquid containing 36mg/ml pronated nicotine will be administered with cooling e-cigarette flavor.

OTHERE-liquid Flavor 3

E-liquid containing 36mg/ml pronated nicotine will be administered with unflavored e-cigarette flavor.

Sponsors

Yale University
Lead SponsorOTHER
National Institute on Drug Abuse (NIDA)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Masking description

Double blind, both participant and investigator will be blind to e-liquid being administered

Intervention model description

Within subject design, all participants will receive all flavors

Eligibility

Sex/Gender
ALL
Age
21 Years to 44 Years
Healthy volunteers
Yes

Inclusion criteria

* 21-44 years old * Able to read/write * Current cigarette smoking * Recent E-cig Exposure (\>/= 10 uses in past 6 mo.) * Urine cot \>200ng/ml * Willing to abstain from nicotine/tobacco 6-8hrs prior to lab session * Not looking to quit

Exclusion criteria

* Untreated chronic medical conditions * Non-stable Rx medication * Illicit drug use * Pregnant, trying to become pregnant, breastfeeding * Not fully vaccinated for Coronavirus (e.g. COVID-19)

Design outcomes

Primary

MeasureTime frameDescription
Appealimmediately after intervention, up to 15 minutesChange in appeal at each flavor as measured by the computerized Labeled Hedonic Scale (LHS). Participants will self-report their responses using a computer mouse to indicate where on the scale response falls. The Labeled Hedonic Scale (LHS) is a bipolar category ratio scale that ranges from -100 (most disliked) to 100 (most liked), with 'neither liked nor disliked' as midpoint.
Sensory Effectsimmediately after intervention, up to 15 minutesChange in sweetness, coolness, irritation, and bitterness at each flavor as measured by the computerized Generalized Labeled Magnitude Scale (gLMS). Participants will self-report their responses using a computer mouse to indicate where on the scale response falls. The Generalized Labeled Magnitude Scales (gLMS) are category ratio scales with seven semantic labels: "no sensation", "barely detectable", "weak", "moderate", "strong", "very strong", and "strongest imaginable", positioned quasi-logarithmically as per empirically determined semantic magnitudes on a 0-100 scale (strongest imaginable at the 100 end).
Reinforcing Efficacyimmediately after intervention, up to 15 minutesChange in reinforcing value at each flavor. Participants will use the multiple choice procedure to self-report their responses using a computer mouse to indicate where on the scale response falls. Following each puffing bout, participants will be asked to make discrete hypothetical choices between 10-puffs of the e-cig they had just used or a series of 44 monetary values ($0.25-$15.06). The minimum monetary value at which money is chosen over the e-cig puffs is a contingency-based estimate of e-cig value. At the end of each lab session, participants will be given a choice between another 10 e-cig puffs or one of the monetary amounts they picked in the Multiple Choice Procedures completed earlier.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORDanielle Davis

Yale University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026